Spectrum Pharmaceuticals

.

FDA OK’s Spectrum Cancer Drug for Wider Use

Spectrum Pharmaceuticals

An Irvine drug maker, Spectrum Pharmaceuticals Inc., has said that it got regulatory approval for an expanded use of a cancer drug.

Spectrum said that the FDA approved Zevalin as an early treatment for a blood cancer, in patients with non-Hodgkin's lymphoma. The drug was used previously on patients whose tumors did not respond to other treatments.

Spectrum Pharmaceuticals inks 50:50 JV pact with Cell Therapeutics

Spectrum Pharmaceuticals inks 50:50 JV pact with Cell Therapeutics Spectrum Pharmaceuticals and Cell Therapeutics have entered into an agreement to form a 50:50 owned joint venture, RIT Oncology, to commercialize and develop Zevalin in the United States.

Latest News

Millions of Dressers and Chests Recalled by IKEA  Following Deaths and Injuries
Pepsi to Reintroduce Diet Coke with Aspartame
Volkswagen Agrees to Pay $14.7 Billion as Settlement in the U.S Related to Diese
Hawaii enrols all gun owners into FBI Database for monitoring
Ten people injured at California rally
IMF’s Christine Lagarde Says Impact of Brexit will Depend on What Move Policy Ma
Oil Prices Tumble with British Pound Facing a Fresh Fall
Gang violence kills two people at dance studio in Fort Worth
George Willto leaveRepublican Party because of Trump
DoubleLine Capital Sold Off All its European Equities Holdings following a Huge
Qualcomm Files Complaint against Meizu with Beijing Authorities over Intellectua
Barnes & Noble Broadening its Business Model Venturing into a Beer and Wine Stor
Syndicate content